Federal Supply Schedule 36F79724D0189

Award Date 9/15/24
Last Date to Order 9/14/29
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This contract IDV is a Federal Supply Schedule (FSS) contract under Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products, awarded to Athena Bioscience, LLC by the Department of Veterans Affairs (VA), Veterans Integrated Service Network 12. The contract has a ceiling value of $25,000.00 and a period of performance from May 4, 2024 to September 14, 2024. As an FSS contract, this is a multiple award vehicle that allows federal agencies to purchase the awarded products and...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 12 to Civicascript LLC, a non-profit limited liability company. The contract, valued at a ceiling of $225,000.00, is for the delivery of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS to the VA and has a period of performance through August 14, 2029. As a Federal Supply Schedule contract, this is a multiple award vehicle that allows ordering from...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) to Thea Pharma, Inc., is for the provision of pharmaceutical and hematology-related products under Schedule 65 I B. The contract has a ceiling value of $25,000.00 and a period of performance through February 1, 2023. As a Federal Supply Schedule agreement, this contract provides a pre-negotiated catalog of products and services that can be ordered by federal agencies as needed. The specific...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Vantive US Healthcare LLC. The contract provides for drugs, pharmaceuticals, and hematology related products under Federal Supply Schedule 65 IB. With a potential value of $25,000 and a period of performance through August 2024, this multiple-award schedule aims to ensure Veterans receive needed medical supplies and treatments. The...
This Federal Supply Schedule contract was awarded to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business, by the Department of Veterans Affairs' Veterans Integrated Service Network 12. The contract has a ceiling value of $225,000.00 and a period of performance through May 14, 2030. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the FSS 65 I B schedule. While the specific products and services were not detailed...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to Pharmaessentia USA Corp, a for-profit organization, on June 1, 2022. The contract has a ceiling value of $6,000,000.00 and a period of performance ending on May 31, 2027. The contract is for the procurement of pharmaceutical and hematology-related products under Federal Supply Schedule 65 IB. As a Federal Supply Schedule contract, it allows for the placement of individual task orders against the...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, is for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Validus Pharmaceuticals, LLC, a for-profit limited liability company that manufactures goods. The contract has a ceiling value of $2,420,310.00 and a period of performance from April 1, 2023 to March 31, 2028. As a Federal Supply Schedule contract, it is a...
The Federal Supply Schedule contract number 36F79725D0117 was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to The Anthos Group, Inc. as the prime contractor. This multiple-award contract has a period of performance from April 15, 2025 to April 14, 2030 and a ceiling value of $225,000.00. The contract is for the provision of drugs, pharmaceuticals, and hematology-related products under the Federal Supply Schedule 65 I B. The Anthos Group, Inc. is a...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to Agepha Pharma USA LLC, a foreign-owned, self-certified small disadvantaged business and woman-owned small business. The contract, under FSS Schedule 65 IB for Drugs, Pharmaceuticals, & Hematology Related Products, has a ceiling value of $25,000.00 and a period of performance through June 14, 2024. The purpose of this interim agreement is to provide the VA with access to a variety of pharmaceutical...
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency under the U.S. Department of Veterans Affairs. The contract has an award date of September 29, 2024 and a ceiling value of $225,000.00, with a period of performance through September 28, 2029. The contract is for the provision of "Drugs, Pharmaceuticals, & Hematology Related Products" under FSS category 65 I B. The prime contractor is Leading Pharma...
  • 36F79724D0189
    Federal Supply Schedule
  • -
    Blanket Purchase Agreements

This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12, a civilian agency within the U.S. Department of Veterans Affairs. The contract has a ceiling value of $225,000.00 and a period of performance from September 15, 2024 to September 14, 2029.

The contract is for the procurement of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, as described in the Federal Supply Schedule. The prime contractor is Athena Bioscience, LLC, a for-profit organization. The contract was awarded without any set-asides and is a multiple award, meaning other vendors can also be awarded task orders under this contract vehicle. The scope of the contract aims to provide the VA with a range of pharmaceutical and hematology-related products to support the medical needs of veterans under the agency's purview.

Generated 12/3/24, 9:45 AM